Verapamil
(DOQPXTMNIUCOSY-UHFFFAOYSA-N)
Structure
- SMILES
- COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C.Cl
- Molecular Formula:
- C27H39ClN2O4
- Molecular Weight:
- 491.063
- Log P:
- 5.8951
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 1
- TPSA:
- 63.95
- CAS Number(s):
- 152-11-4; 23313-68-0
Synonym(s)
1.
Verapamil
2.
Iproveratril
3.
Calan
4.
Cordilox
5.
Dexverapamil
6.
Falicard
7.
Finoptin
8.
Isoptin
9.
Isoptine
10.
Izoptin
11.
Lekoptin
12.
Verapamil Hydrochloride
13.
Hydrochloride, Verapamil
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Completed Suicide | FAERS: 198 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Drug ineffective | FAERS: 141 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 3 | Hypotension | FAERS: 92 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Overdose | FAERS: 83 | US FAERS | |
| 5 | Dizziness | FAERS: 47 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 6 | Bradycardia | FAERS: 44 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 7 | Cardiac Arrest | FAERS: 41 | US FAERS | |
| 8 | Malaise | FAERS: 36 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 9 | Toxicity to various agents | FAERS: 34 | US FAERS | |
| 10 | Suicide attempt | FAERS: 32 | US FAERS | |
| 11 | Medication Error | FAERS: 29 | US FAERS | |
| 12 | Headache | FAERS: 28 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 13 | Nausea | FAERS: 27 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 14 | Feeling abnormal | FAERS: 25 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Constipation | FAERS: 23 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 16 | Drug toxicity | FAERS: 23 | US FAERS | |
| 17 | Palpitations | FAERS: 23 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 18 | Blood pressure inadequately controlled | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Asthenia | FAERS: 18 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 20 | Atrioventricular Block | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Metabolic acidosis | FAERS: 18 | US FAERS | |
| 22 | Somnolence | FAERS: 18 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Lethargy | FAERS: 16 | US FAERS | |
| 24 | Chest Pain | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Drug effect incomplete | FAERS: 14 | US FAERS | |
| 26 | Fatigue | FAERS: 14 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 27 | Incorrect dose administered | FAERS: 14 | US FAERS | |
| 28 | Respiratory arrest | FAERS: 14 | US FAERS | |
| 29 | Vomiting | FAERS: 14 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 30 | Urticaria | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 31 | Drug ineffective for unapproved indication | FAERS: 12 | US FAERS | |
| 32 | Shock | FAERS: 12 | US FAERS | |
| 33 | Accidental overdose | FAERS: 11 | US FAERS | |
| 34 | Chest discomfort | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Intentional product misuse | FAERS: 11 | US FAERS | |
| 36 | Pruritus | FAERS: 11 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 37 | Feeling jittery | FAERS: 10 | US FAERS | |
| 38 | Hypersensitivity | FAERS: 10 | US FAERS | |
| 39 | Ileus | FAERS: 10 | US FAERS | |
| 40 | Atrial Fibrillation | FAERS: 9 | US FAERS | |
| 41 | Intentional misuse | FAERS: 9 | US FAERS | |
| 42 | Product use issue | FAERS: 9 | US FAERS | |
| 43 | Reaction to drug excipients | FAERS: 8 | US FAERS | |
| 44 | Supraventricular tachycardia | FAERS: 8 | US FAERS | |
| 45 | Tachycardia | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 46 | Anuria | FAERS: 7 | US FAERS | |
| 47 | Depressed Level of Consciousness | FAERS: 7 | US FAERS | |
| 48 | Hypoxia | FAERS: 7 | US FAERS | |
| 49 | Leukocytosis | FAERS: 7 | US FAERS | |
| 50 | Pharmaceutical product complaint | FAERS: 7 | US FAERS | |
| 51 | Abdominal discomfort | FAERS: 6 | US FAERS | |
| 52 | Intentional drug misuse | FAERS: 6 | US FAERS | |
| 53 | Sinus bradycardia | FAERS: 6 | US FAERS | |
| 54 | Vasoplegia syndrome | FAERS: 6 | US FAERS | |
| 55 | Alopecia | FAERS: 5 | US FAERS | |
| 56 | Myocardial Infarction | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 57 | Myocardial Stunning | FAERS: 5 | US FAERS | |
| 58 | Poisoning | FAERS: 5 | US FAERS | |
| 59 | Product substitution issue | FAERS: 5 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 60 | Syncope | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 61 | Throat irritation | FAERS: 5 | US FAERS | |
| 62 | Acute respiratory failure | FAERS: 4 | US FAERS | |
| 63 | Blood creatinine increased | FAERS: 4 | US FAERS | |
| 64 | Cardiotoxicity | FAERS: 4 | US FAERS | |
| 65 | Cerebrovascular accident | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 66 | Drug dispensing error | FAERS: 4 | US FAERS | |
| 67 | Pain | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Product use in unapproved indication | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 69 | Pulmonary Embolism | FAERS: 4 | US FAERS | |
| 70 | Respiratory Failure | FAERS: 4 | US FAERS | |
| 71 | Unevaluable event | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 72 | Accidental exposure | FAERS: 3 | US FAERS | |
| 73 | Activities of daily living impaired | FAERS: 3 | US FAERS | |
| 74 | Acute kidney injury | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Amnesia | FAERS: 3 | US FAERS | |
| 76 | Atrial thrombosis | FAERS: 3 | US FAERS | |
| 77 | Blood brain barrier defect | FAERS: 3 | US FAERS | |
| 78 | Blood glucose increased | FAERS: 3 | US FAERS | |
| 79 | Blood pH decreased | FAERS: 3 | US FAERS | |
| 80 | Blood potassium decreased | FAERS: 3 | US FAERS | |
| 81 | Burning sensation | FAERS: 3 | US FAERS | |
| 82 | Dyspepsia | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 83 | Flushing | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 84 | Lip swelling | FAERS: 3 | US FAERS | |
| 85 | Peripheral swelling | FAERS: 3 | US FAERS | |
| 86 | Petechiae | FAERS: 3 | US FAERS | |
| 87 | Product coating issue | FAERS: 3 | US FAERS | |
| 88 | Sepsis | FAERS: 3 | US FAERS | |
| 89 | Therapeutic response unexpected | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 90 | Vasospasm | FAERS: 3 | US FAERS | |
| 91 | Wrong drug administered | FAERS: 3 | US FAERS | |
| 92 | Abdominal Pain | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 93 | Alcohol interaction | FAERS: 2 | US FAERS | |
| 94 | Altered state of consciousness | FAERS: 2 | US FAERS | |
| 95 | Arterial thrombosis | FAERS: 2 | US FAERS | |
| 96 | Arthralgia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 97 | Asthma | FAERS: 2 | US FAERS | |
| 98 | Aura | FAERS: 2 | US FAERS | |
| 99 | Cardiac Flutter | FAERS: 2 | US FAERS | |
| 100 | Dehydration | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | Drug administration error | FAERS: 2 | US FAERS | |
| 102 | Drug exposure during pregnancy | FAERS: 2 | US FAERS | |
| 103 | Ear discomfort | FAERS: 2 | US FAERS | |
| 104 | Electrolyte imbalance | FAERS: 2 | US FAERS | |
| 105 | Endocarditis | FAERS: 2 | US FAERS | |
| 106 | Erectile dysfunction | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 107 | Flatulence | FAERS: 2 | US FAERS | |
| 108 | Fluid overload | FAERS: 2 | US FAERS | |
| 109 | General physical health deterioration | FAERS: 2 | US FAERS | |
| 110 | Incorrect route of drug administration | FAERS: 2 | US FAERS | |
| 111 | Infarction | FAERS: 2 | US FAERS | |
| 112 | Ligament rupture | FAERS: 2 | US FAERS | |
| 113 | Lymphomatoid Papulosis | FAERS: 2 | US FAERS | |
| 114 | Migraine with Aura | FAERS: 2 | US FAERS | |
| 115 | Myalgia | FAERS: 2 | US FAERS | |
| 116 | No adverse event | FAERS: 2 | US FAERS | |
| 117 | Occupational exposure to product | FAERS: 2 | US FAERS | |
| 118 | Oliguria | FAERS: 2 | US FAERS | |
| 119 | Pallor | FAERS: 2 | US FAERS | |
| 120 | Peritonitis | FAERS: 2 | US FAERS | |
| 121 | Pneumonia | FAERS: 2 | US FAERS | |
| 122 | Poor quality drug administered | FAERS: 2 | US FAERS | |
| 123 | Presyncope | FAERS: 2 | US FAERS | |
| 124 | Product quality issue | FAERS: 2 | US FAERS | |
| 125 | Pulmonary congestion | FAERS: 2 | US FAERS | |
| 126 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 127 | Swelling | FAERS: 2 | US FAERS | |
| 128 | Therapeutic response unexpected with drug substitution | FAERS: 2 | US FAERS | |
| 129 | Transcription medication error | FAERS: 2 | US FAERS | |
| 130 | Tremor | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 131 | Urinary Incontinence | FAERS: 2 | US FAERS | |
| 132 | Ventricular Dysfunction | FAERS: 2 | US FAERS | |
| 133 | Weight decreased | FAERS: 2 | US FAERS | |
| 134 | Wrong product administered | FAERS: 2 | US FAERS | |
| 135 | treatment failure | FAERS: 2 | US FAERS | |
| 136 | Abasia | FAERS: 1 | US FAERS | |
| 137 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 138 | Acidosis | FAERS: 1 | US FAERS | |
| 139 | Adverse event | FAERS: 1 | US FAERS | |
| 140 | Agitation | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 141 | Alanine Aminotransferase Increased | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 142 | Ammonia increased | FAERS: 1 | US FAERS | |
| 143 | Anorexia | FAERS: 1 | US FAERS | |
| 144 | Anxiety | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 145 | Aphonia | FAERS: 1 | US FAERS | |
| 146 | Arthropathy | FAERS: 1 | US FAERS | |
| 147 | Aspartate Aminotransferase Increased | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 148 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 149 | Atrial tachycardia | FAERS: 1 | US FAERS | |
| 150 | Back Pain | FAERS: 1 | US FAERS | |
| 151 | Blood alcohol increased | FAERS: 1 | US FAERS | |
| 152 | Blood creatine increased | FAERS: 1 | US FAERS | |
| 153 | Blood glucose abnormal | FAERS: 1 | US FAERS | |
| 154 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 155 | Blood iron decreased | FAERS: 1 | US FAERS | |
| 156 | Blood magnesium decreased | FAERS: 1 | US FAERS | |
| 157 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 158 | Blood pressure immeasurable | FAERS: 1 | US FAERS | |
| 159 | Blood prolactin increased | FAERS: 1 | US FAERS | |
| 160 | Blood triglycerides increased | FAERS: 1 | US FAERS | |
| 161 | Blood urea increased | FAERS: 1 | US FAERS | |
| 162 | Bradykinesia | FAERS: 1 | US FAERS | |
| 163 | Bradyphrenia | FAERS: 1 | US FAERS | |
| 164 | Bronchitis | FAERS: 1 | US FAERS | |
| 165 | Cardioactive drug level above therapeutic | FAERS: 1 | US FAERS | |
| 166 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 167 | Choking | FAERS: 1 | US FAERS | |
| 168 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 169 | Cold sweat | FAERS: 1 | US FAERS | |
| 170 | Culture urine positive | FAERS: 1 | US FAERS | |
| 171 | Cyanosis | FAERS: 1 | US FAERS | |
| 172 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 173 | Diabetes Mellitus | FAERS: 1 | US FAERS | |
| 174 | Diabetic Ketoacidosis | FAERS: 1 | US FAERS | |
| 175 | Discomfort | FAERS: 1 | US FAERS | |
| 176 | Disease recurrence | FAERS: 1 | US FAERS | |
| 177 | Diverticulitis | FAERS: 1 | US FAERS | |
| 178 | Drooling | FAERS: 1 | US FAERS | |
| 179 | Drug abuse | FAERS: 1 | US FAERS | |
| 180 | Drug dose omission | FAERS: 1 | US FAERS | |
| 181 | Drug effective for unapproved indication | FAERS: 1 | US FAERS | |
| 182 | Drug withdrawal syndrome | FAERS: 1 | US FAERS | |
| 183 | Dysgeusia | FAERS: 1 | US FAERS | |
| 184 | Dyspareunia | FAERS: 1 | US FAERS | |
| 185 | Dysphonia | FAERS: 1 | US FAERS | |
| 186 | Dystonia | FAERS: 1 | US FAERS | |
| 187 | Echocardiogram abnormal | FAERS: 1 | US FAERS | |
| 188 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 189 | Electrocardiogram abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 190 | Electrocardiogram poor R-wave progression | FAERS: 1 | US FAERS | |
| 191 | Electromechanical dissociation | FAERS: 1 | US FAERS | |
| 192 | Environmental Exposure | FAERS: 1 | US FAERS | |
| 193 | Epistaxis | FAERS: 1 | US FAERS | |
| 194 | Eructation | FAERS: 1 | US FAERS | |
| 195 | Erythema Multiforme | FAERS: 1 | US FAERS | |
| 196 | Erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 197 | Feeling Cold | FAERS: 1 | US FAERS | |
| 198 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 199 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 200 | General physical condition abnormal | FAERS: 1 | US FAERS | |
| 201 | Glasgow coma scale abnormal | FAERS: 1 | US FAERS | |
| 202 | Hemiparesis | FAERS: 1 | US FAERS | |
| 203 | Hyperventilation | FAERS: 1 | US FAERS | |
| 204 | Hypothalamo-pituitary disorder | FAERS: 1 | US FAERS | |
| 205 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 206 | Incontinence | FAERS: 1 | US FAERS | |
| 207 | Influenza | FAERS: 1 | US FAERS | |
| 208 | Intervertebral Disc Degeneration | FAERS: 1 | US FAERS | |
| 209 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 210 | Joint swelling | FAERS: 1 | US FAERS | |
| 211 | Laryngospasm | FAERS: 1 | US FAERS | |
| 212 | Left Ventricular Hypertrophy | FAERS: 1 | US FAERS | |
| 213 | Lentigo | FAERS: 1 | US FAERS | |
| 214 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 215 | Mammary duct ectasia | FAERS: 1 | US FAERS | |
| 216 | Medication residue present | FAERS: 1 | US FAERS | |
| 217 | Middle insomnia | FAERS: 1 | US FAERS | |
| 218 | Moaning | FAERS: 1 | US FAERS | |
| 219 | Muscle Fatigue | FAERS: 1 | US FAERS | |
| 220 | Muscle Rigidity | FAERS: 1 | US FAERS | |
| 221 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 222 | Myoclonic Epilepsy | FAERS: 1 | US FAERS | |
| 223 | Myoclonus | FAERS: 1 | US FAERS | |
| 224 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 225 | Necrosis | FAERS: 1 | US FAERS | |
| 226 | Nervousness | FAERS: 1 | US FAERS | |
| 227 | Neuralgia | FAERS: 1 | US FAERS | |
| 228 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 229 | Osteoporosis | FAERS: 1 | US FAERS | |
| 230 | PCO2 decreased | FAERS: 1 | US FAERS | |
| 231 | PO2 decreased | FAERS: 1 | US FAERS | |
| 232 | Pancreatitis | FAERS: 1 | US FAERS | |
| 233 | Pneumatosis intestinalis | FAERS: 1 | US FAERS | |
| 234 | Post procedural complication | FAERS: 1 | US FAERS | |
| 235 | Postoperative thrombosis | FAERS: 1 | US FAERS | |
| 236 | Prescription drug used without a prescription | FAERS: 1 | US FAERS | |
| 237 | Product dose omission | FAERS: 1 | US FAERS | |
| 238 | Product physical issue | FAERS: 1 | US FAERS | |
| 239 | Prothrombin level decreased | FAERS: 1 | US FAERS | |
| 240 | Psoriasis | FAERS: 1 | US FAERS | |
| 241 | Rales | FAERS: 1 | US FAERS | |
| 242 | Rash erythematous | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 243 | Regurgitation | FAERS: 1 | US FAERS | |
| 244 | Respiratory Depression | FAERS: 1 | US FAERS | |
| 245 | Schizophrenia | FAERS: 1 | US FAERS | |
| 246 | Septic Shock | FAERS: 1 | US FAERS | |
| 247 | Sick Sinus Syndrome | FAERS: 1 | US FAERS | |
| 248 | Skin laceration | FAERS: 1 | US FAERS | |
| 249 | Skin reaction | FAERS: 1 | US FAERS | |
| 250 | Sopor | FAERS: 1 | US FAERS | |
| 251 | Staphylococcus test positive | FAERS: 1 | US FAERS | |
| 252 | Stevens-Johnson Syndrome | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 253 | Stomatitis | FAERS: 1 | US FAERS | |
| 254 | Sudden death | FAERS: 1 | US FAERS | |
| 255 | Tension Headache | FAERS: 1 | US FAERS | |
| 256 | Tinnitus | FAERS: 1 | US FAERS | |
| 257 | Tongue biting | FAERS: 1 | US FAERS | |
| 258 | Troponin increased | FAERS: 1 | US FAERS | |
| 259 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 260 | Urinary Retention | FAERS: 1 | US FAERS | |
| 261 | Urinary tract infection staphylococcal | FAERS: 1 | US FAERS | |
| 262 | Vascular resistance systemic decreased | FAERS: 1 | US FAERS | |
| 263 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 264 | Ventricular arrhythmia | FAERS: 1 | US FAERS | |
| 265 | Vertigo | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 266 | Wheezing | FAERS: 1 | US FAERS | |
| 267 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 268 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 269 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 270 | Angina Pectoris | Canada Vigilance: 1 | Canada Vigilance | |
| 271 | Blood alkaline phosphatase increased | Canada Vigilance: 3 | Canada Vigilance | |
| 272 | Blood lactate dehydrogenase increased | Canada Vigilance: 1 | Canada Vigilance | |
| 273 | Bronchospasm | Canada Vigilance: 1 | Canada Vigilance | |
| 274 | Cataract | Canada Vigilance: 1 | Canada Vigilance | |
| 275 | Conjunctivitis | Canada Vigilance: 1 | Canada Vigilance | |
| 276 | Delirium | Canada Vigilance: 1 | Canada Vigilance | |
| 277 | Dementia | Canada Vigilance: 1 | Canada Vigilance | |
| 278 | Disorientation | Canada Vigilance: 1 | Canada Vigilance | |
| 279 | Gingival Hypertrophy | Canada Vigilance: 1 | Canada Vigilance | |
| 280 | Hemiplegia | Canada Vigilance: 1 | Canada Vigilance | |
| 281 | Hepatotoxicity | Canada Vigilance: 1 | Canada Vigilance | |
| 282 | Hyperkinesia | Canada Vigilance: 1 | Canada Vigilance | |
| 283 | Muscle strain | Canada Vigilance: 1 | Canada Vigilance | |
| 284 | Polyuria | Canada Vigilance: 1 | Canada Vigilance | |
| 285 | Proctitis | Canada Vigilance: 1 | Canada Vigilance | |
| 286 | Product residue present | Canada Vigilance: 1 | Canada Vigilance | |
| 287 | Rhinitis | Canada Vigilance: 1 | Canada Vigilance | |
| 288 | Serum Sickness | Canada Vigilance: 1 | Canada Vigilance | |
| 289 | Skin Wrinkling | Canada Vigilance: 1 | Canada Vigilance | |
| 290 | Tension | Canada Vigilance: 1 | Canada Vigilance | |
| 291 | Therapeutic product effect decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 292 | Toxic Epidermal Necrolysis | Canada Vigilance: 1 | Canada Vigilance | |
| 293 | Vasculitis | Canada Vigilance: 1 | Canada Vigilance | |
| 294 | Visual Impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 295 | jaundice | Canada Vigilance: 4 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.